Related Experiment Video
Updated: Jul 9, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Community-acquired pneumonia in children]
Dominique Gendrel1, Florence Moulin
1Hôital Saint-Vincent de Paul, 75674 Paris. dominique.gendrel@svp.aphp.fr
La Revue Du Praticien
|December 22, 2007
Summary
Empiric antibiotic therapy for childhood community-acquired pneumonia is common due to varied causes. Amoxicillin is recommended, with macrolides for suspected Mycoplasma pneumoniae infections.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Respiratory Medicine
Context:
- Community-acquired pneumonia (CAP) in children presents diagnostic challenges.
- Empiric antibiotic selection is complicated by diverse etiologies and unreliable diagnostic markers.
- Streptococcus pneumoniae and Mycoplasma pneumoniae are significant pathogens.
Purpose:
- To review the challenges in diagnosing and treating pediatric CAP.
- To provide guidance on empiric antibiotic selection based on likely pathogens and resistance patterns.
- To highlight the role of amoxicillin and macrolides in managing pediatric pneumonia.
Summary:
- Empiric antibiotic therapy is frequently used for pediatric CAP due to numerous causes.
- Streptococcus pneumoniae causes severe pneumonia, while Mycoplasma pneumoniae is common in older children.
- Diagnostic methods lack specificity; high procalcitonin levels are a reliable indicator.
- Amoxicillin is the preferred antibiotic for pneumococcal coverage, including resistant strains.
- Macrolides are indicated for suspected Mycoplasma pneumoniae infections, especially with clinical failure of amoxicillin.
- Viral pneumonia diagnosis is difficult, but viral infections can predispose to bacterial pneumonia.
Impact:
- Informs clinical practice regarding appropriate empiric antibiotic choices for pediatric pneumonia.
- Emphasizes the importance of considering specific pathogens like Streptococcus pneumoniae and Mycoplasma pneumoniae.
- Highlights the need for continued research, especially in vaccinated populations, to refine treatment guidelines.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps: